The Brandon Case: Sell Factors and Forced Medication Limits

In United States v. Brandon, 158 F.3d 947, the Sixth Circuit held that the federal government cannot forcibly medicate a non-dangerous pretrial detainee for the sole purpose of restoring competency to stand trial without first providing a judicial hearing. The decision recognized a Fifth Amendment liberty interest in refusing antipsychotic drugs and rejected the idea that the Bureau of Prisons’ internal administrative process was enough when the only justification for medication was getting the defendant to trial. The Supreme Court’s later decision in Sell v. United States now supplies the controlling national test, but Brandon’s reasoning about judicial oversight for non-dangerous detainees remains the ancestor of that rule.¹²

What the Brandon Case Decided

Ralph E. Brandon was a pretrial detainee facing a federal charge for sending a threatening communication through the mail. He was held at a federal medical center, where clinicians concluded he had a mental disorder that made him incompetent to stand trial. Their proposed fix was antipsychotic medication. Brandon refused.

The government’s position was that its interest in bringing him to trial was enough, on its own, to justify overriding that refusal through the facility’s internal process. Brandon argued that forcing mind-altering drugs on a person who had not been convicted of anything violated his constitutional rights. The Sixth Circuit sided with Brandon on the procedural question: when a pretrial detainee is not dangerous and the sole aim of medication is trial competency, the detainee is entitled to a judicial hearing before the government can proceed.¹

Why Non-Dangerous Detainees Get More Protection

The Fifth Amendment’s Due Process Clause gives every federal detainee a liberty interest in refusing antipsychotic injections. Pretrial detainees are presumed innocent, and courts treat that presumption as entitling them to at least the protections available to convicted prisoners, plus specific protections tied to the fairness of the coming trial.³⁴

The level of process required depends on why the government wants to medicate. If an inmate is dangerous to themselves or others, medication may be authorized administratively when it is in the person’s medical interest and needed for institutional safety. That route rests on an emergency-style justification that a non-dangerous detainee, by definition, does not present. Brandon’s contribution was to say that the administrative shortcut cannot be borrowed to solve a purely trial-related problem. Where the only reason to inject someone is to make them fit to prosecute, a neutral judge has to weigh that decision.³¹

The Sell Factors That Now Control

For the substantive standard, the current governing law comes from Sell v. United States. To force medication on a non-dangerous defendant for competency-restoration purposes, the court must find all of the following:²

The medication is medically appropriate and in the patient’s best medical interest.
Forced medication will significantly further the government’s interest, meaning it is substantially likely to restore competency and substantially unlikely to produce side effects that interfere with the trial.
The treatment is necessary, in that less intrusive alternatives are unlikely to achieve the same result.
The government has an important interest in bringing the individual to trial for a serious crime.

Seriousness is assessed case by case rather than through a fixed list of offenses. Special circumstances can also cut against the government’s interest. A defendant who has already been confined for a long stretch, for example, gives the government less to gain from a trial, which weakens the case for overriding refusal.²

The medical-appropriateness and side-effect prongs matter in practice. Even where a serious charge is in play, the government must show that the drugs will not impair the defendant’s ability to communicate with counsel during trial. If it cannot show that forced medication is the least intrusive route to a fair trial, the request fails.²

When Administrative Hearings Still Apply

The Bureau of Prisons has its own procedure under 28 CFR § 549.46 for involuntarily medicating an inmate who is dangerous or gravely disabled. That process includes 24 hours’ written notice of the hearing, a presiding independent psychiatrist who is not the inmate’s treating clinician, the inmate’s right to appear and present evidence, a staff representative when needed, a written decision, and an appeal to the institution’s mental health division administrator before medication is given.⁵

That administrative track remains available for its intended purpose. It does not, however, cover competency restoration. When the sole reason for medication is to make a non-dangerous defendant fit for trial, the § 549.46 hearing is not the right forum; a federal court order under the Sell framework is what the government has to obtain.⁵²

1
Justia. United States v. Brandon
2
LII / Legal Information Institute. Sell v. United States
3
Justia. Washington v. Harper
4
Justia. Riggins v. Nevada
5
eCFR. 28 CFR § 549.46